Executive Overview: The Global Montelukast Sodium Market The global montelukast sodium market is experiencing significant expansion, driven by increasing prevalence of respiratory disorders and growing demand for effective leukotriene receptor antagonists. Montelukast sodium (CAS 151767-02-1), a critical therapeutic agent for asthma, allergic rhinitis, and urticaria, demonstrates robust market dynamics​ with the global market valued at USD 504.7 million in 2024​ and projected to reach USD 1.1 billion by 2030, reflecting a compound annual growth rate (CAGR) of 14.1%​ . Alternative market analysis indicates the market was valued at USD 4.64 billion in 2024, with projections reaching USD 7.02 billion by 2031​ at a CAGR of 6.1%​ . This pharmaceutical compound…